Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients

Annals of the Rheumatic Diseases

Volumn 61, Issue 8, 2002, Pages 714-717

  Vargas Alarcon G ^a   Pacheco Tena, C ^c   Castillo, E ^a   Londono J D ^b   Hernandez Pacheco G ^a   Cardiel, M H ^b   Granados, J ^b   Burgos Vargas, R ^c  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; HLA B27 ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA B15; HLA-B15;

ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENE EXPRESSION; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HLA TYPING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MEXICO; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SPONDYLOARTHROPATHY; STATISTICAL ANALYSIS; STUDENT T TEST; ADULT; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; ONSET AGE;

ADULT; AGE OF ONSET; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-B ANTIGENS; HLA-B27 ANTIGEN; HLA-DR1 ANTIGEN; HUMAN; MALE; MEXICO; SPONDYLITIS, ANKYLOSING; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0035997485     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.8.714     Document Type: Article

References (30)

1. An overview of clinical spectrum and heterogeneity of spondyloarthropathies
2. Features of spondyloarthropathies around the world
3. Immunogenetics of spondyloarthropathies
4. HLA-B27, onkylosing spondylitis and the spondyloarthropothies
5. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: A comparison of relatives of spondylitis patients with the general population
6. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors
7. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis
8. HLA-DR4 in ankylosing spondylitis with different patterns of joint involvement
9. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27 + patients
10. HLA-A*9, a probable secondary susceptibility marker to ankylosing spondylitis in Basque patients
11. HLA-DR8 and acute anterior uveitis in ankylosing spondylitis
12. HLA-B27 in Mexican patients with ankylosing spondylitis
13. HLA-B27 and ankylosing spondylitis in the Mexican mestizo population
14. Characterization of B27 haplotypes by oligotyping and genomic sequencing in the Mexican mestizo population with ankylosing spondylitis: Juvenile and adult onset
15. HLA-B and complotypes in Mexican patients with seronegative spondyloarthropathies
16. HLA-DRB1*08 influences the development of disease in Mexican mestizo with spondyloarthropathy
17. The LMP2 polymorphism is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican subjects with ankylosing spondylitis
18. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy
19. New York symposium on population studies in the rheumatic diseases: New diagnostic criteria
20. Third international workshop on reactive arthritis. An overview
21. Rapid DNA isolation for enzymatic and hybridization analysis
22. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index
23. A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index
24. HLA and disease associations: Detecting the strongest association
25. On estimating the relation between blood group and disease
26. HLA antigens in seronegative spondyloarthropathies: Reactive arthritis and arthritis in ankylosing spondylitis: Relation to gut inflammation
27. The evolution of spondyloarthropathies in relation to gut history. II Histological aspects
28. A comparative study of HLA genes in HLA-B27 positive ankylosing spondylitis and HLA-B27 positive peripheral reactive arthritis
29. Ankylosing spondylitis in the Mexican mestizo: Patterns of disease according to age at onset
30. Ankylosing spondylitis and related diseases in the Mexican mestizo